vimarsana.com

Page 15 - எங்களுக்கு தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covaxin neutralises both Alpha, Delta variants of Covid effectively, research by top US health institute finds

Covaxin neutralises both Alpha, Delta variants of Covid effectively, research by top US health institute finds SECTIONS Covaxin neutralises both Alpha, Delta variants of Covid effectively, research by top US health institute findsET Online Last Updated: Jun 30, 2021, 11:01 AM IST Share Synopsis The vaccine has so far been given to around 25 million recipients in India and elsewhere. Interim results from Covaxin s Phase 3 trial have reportedly shown over 78% efficacy against symptomatic disease, 100% efficacy against severe infection and 70% efficacy against asymptomatic infection. India s Covaxin effectively neutralises Delta and Alpha variants of coronavirus: Top US health institute Bharat Biotech s Covaxin, India s only domestically developed Covid vaccine, can make antibodies that can neutralise both Alpha and

Bharat Biotech s Covaxin effective against Delta variant of coronavirus: Top US research institute

Bharat Biotech s Covaxin effective against Delta variant of coronavirus: Top US research institute Two studies suggest that Bharat Biotech s Covaxin is effective against both Alpha and Delta variants of coronavirus, said the US National Institute of Health (NIH). advertisement UPDATED: June 30, 2021 16:10 IST Covaxin has been administered to roughly 25 million people till date in India and elsewhere. (Image: AFP) Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), effectively neutralises both Alpha and Delta variants of coronavirus, said the US National Institute of Health (NIH). Two studies Study 2 were carried out wherein blood serum from people who had received Covaxin was collected and examined. The

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.